N.C. Pharmaceuticals Private Limited
About N.C. Pharmaceuticals Private Limited
Data last updated:
N.C. Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 20 July 2016.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2016PTC303315. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Anil Kumar Pandey and Mohd Sajid.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 78 Old – 15 Khasra No 162 163 164 Ground Floor New Yadav Enclave Blk C – 1 Prem Nagar III, New Delhi, Delhi, India – 110086.
As per the financials filed for FY 2017, the company reported a revenue of ₹3.27 Lakh. For the same year it recorded a net profit of ₹6,803 (net margin 2.1%) and EBITDA of ₹11,594 (EBITDA margin 3.5%).
Company details
Contact details
N.C. Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address78 Old – 15 Khasra No 162 163 164 Ground Floor New Yadav Enclave Blk C – 1 Prem Nagar III, New Delhi, Delhi, India – 110086
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of N.C. Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of N.C. Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of N.C. Pharmaceuticals Private Limited, buy the company report.
Financials of N.C. Pharmaceuticals Private Limited
FY 2017 filings availableN.C. Pharmaceuticals Private Limited reported revenue of ₹3.27 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹3.27 Lakh |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹11,594 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹6,803 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2016-17 |
|---|---|
| Profitability | |
| EBITDA Margin | 3.5% |
| Net Profit Margin | 2.1% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of N.C. Pharmaceuticals Private Limited, buy the company report.
Board of directors of N.C. Pharmaceuticals Private Limited
N.C. Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Pandey Also directs: Oak Tree Foundation | Director | 20 Jul 2016 | 10 Years 3 Months | As last reported |
| Mohd Sajid | Director | 20 Jul 2016 | 10 Years 3 Months | As last reported |
Peer comparison
N.C. Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Patcure Pharmaceuticals (Belgaum) Private Limited | ₹3.31 Lakh (FY 2016) | 47.0% | Belgaum, Karnataka, India | |||
| Cerxa Lifesciences and Pharmaceuticals Private Limited | ₹3.3 Lakh (FY 2024) | -9.0% | Gautam Buddha Nagar, Uttar Pradesh, India | |||
| N.C. Pharmaceuticals Private Limitedthis company | ₹3.27 Lakh (FY 2017) | ₹6,803 | 2.1% | New Delhi, Delhi, India | ||
| Medineeds Pharmaceuticals Private Limited | ₹3.25 Lakh (FY 2019) | Ranchi, Jharkhand, India | ||||
| Pushpa Pharmaceuticals Private Limited | ₹3.24 Lakh (FY 2023) | -66.0% | Lucknow, Uttar Pradesh, India | |||
| Fysan Pharmaceuticals Private Limited | ₹3.22 Lakh (FY 2020) | -62.0% | Pune, Maharashtra, India |
To see the full peer comparison of N.C. Pharmaceuticals Private Limited, buy the company report.
Auditor
N.C. Pharmaceuticals Private Limited is audited by VAIBHAVGULATI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VAIBHAVGULATI | FY 2017 | 520097 |
Shareholding
The shareholding of N.C. Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of N.C. Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving N.C. Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for N.C. Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
N.C. Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of N.C. Pharmaceuticals Private Limited, buy the company report.
Recent activity
N.C. Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Kawaljeet Singh ceased to be Director on 20 Apr 2018.
Frequently asked questions
N.C. Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
N.C. Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in wholesale, within the trading industry. It was incorporated on 20 July 2016 and is registered under CIN U51909DL2016PTC303315. The company has been struck off by the Registrar of Companies and is no longer operational.
N.C. Pharmaceuticals had 2 directors:
- Anil Kumar Pandey - Director
- Mohd Sajid - Director
The CIN (Corporate Identification Number) of N.C. Pharmaceuticals is U51909DL2016PTC303315. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of N.C. Pharmaceuticals is at 78 Old – 15 Khasra No 162 163 164 Ground Floor New Yadav Enclave Blk C – 1 Prem Nagar III, New Delhi, Delhi, India – 110086.
N.C. Pharmaceuticals was incorporated on 20 July 2016. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of N.C. Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from FY 2017 are in the company report.
No. N.C. Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
N.C. Pharmaceuticals operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
The peers of N.C. Pharmaceuticals by revenue are Patcure Pharmaceuticals (Belgaum) Private Limited, Cerxa Lifesciences and Pharmaceuticals Private Limited, Medineeds Pharmaceuticals Private Limited, Pushpa Pharmaceuticals Private Limited, Fysan Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Kawaljeet Singh ceased to be Director on 20 Apr 2018. Anil Kumar Pandey was appointed as Director on 20 Jul 2016. Mohd Sajid was appointed as Director on 20 Jul 2016.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
